Table 8.
ALT (U/L) | |||
---|---|---|---|
Models | β | 95% CI | P |
One variable model | |||
NAS≥5 | 30.9 | 23.0 – 38.8 | <0.0001 |
NASH diagnosis | 25.5 | 17.3 – 33.7 | <0.0001 |
Two variable models | |||
NAS≥5 | 24.5 | 15.1 – 34.0 | <0.0001 |
NASH Dx | 11.8 | 2.1 – 21.3 | 0.02 |
AST (U/L) | |||
Models | β | 95% CI | P |
One variable model | |||
NAS≥5 | 25.9 | 20.2 – 31.7 | <0.0001 |
NASH diagnosis | 25.7 | 19.8 – 31.6 | <0.0001 |
Two variable models | |||
NAS≥5 | 17.3 | 10.4 – 24.1 | <0.0001 |
NASH Dx | 16.1 | 9.1 – 23.0 | <0.0001 |
Diabetes | |||
Models | OR | 95% CI | P |
One variable model | |||
NAS≥5 | 1.33 | 0.99 – 1.79 | 0.06 |
NASH diagnosis | 1.92 | 1.41 – 2.62 | <0.0001 |
Two variable models | |||
NAS≥5 | 0.90 | 0.63 – 1.29 | 0.58 |
NASH Dx | 2.04 | 1.40 – 2.96 | <0.0001 |
Metabolic Syndrome | |||
Models | OR | 95% CI | P |
One variable model | |||
NAS≥5 | 1.21 | 0.93 – 1.58 | 0.16 |
NASH diagnosis | 1.43 | 1.09 – 1.98 | 0.009 |
Two variable models | |||
NAS≥5 | 0.98 | 0.71 – 1.36 | 0.91 |
NASH Dx | 1.45 | 1.04 – 2.01 | 0.03 |
HOMA-IR | |||
Models | β | 95% CI | P |
One variable model | |||
NAS≥5 | 1.39 | 0.48 – 2.31 | 0.003 |
NASH diagnosis | 1.70 | 0.77 – 2.62 | <0.0001 |
Two variable models | |||
NAS≥5 | 0.68 | −0.41 – 1.77 | 0.22 |
NASH Dx | 1.32 | 0.21 – 2.42 | <0.0001 |
QUICKI (X 1,000 ) | |||
Models | β | 95% CI | P |
One variable model | |||
NAS≥5 | −7.17 | −12.49 – −1.85 | 0.008 |
NASH diagnosis | −9.24 | −14.63 – −3.86 | 0.001 |
Two variable models | |||
NAS≥5 | −3.12 | −9.45 – −3.86 | 0.33 |
NASH Dx | −7.51 | −13.95 – −1.06 | 0.02 |